EU & US market support

Why this matters

Treating “global” as one identical pathway creates documentation and engineering mismatches. We help teams name what differs — without pretending regional frameworks are interchangeable.

Working distinctions

• Device and software pathways use region-specific frameworks (for example MDR/IVDR-oriented EU conformity vs FDA device pathways)
• Drug and biologic programmes may share science while submission vocabulary and procedure mechanics diverge
• Evidence and clinical evaluation expectations can differ even when scientific goals align
• AI-enabled products may face complementary EU AI Act themes alongside MDR/IVDR, and FDA AI/ML guidance on the US side — planning should track both
• Privacy and contracting entities differ by region — use the region control, then see the Imprint
• Public marketing language stays evidence-governed in both regions

What we typically help with

• Making shared scientific core vs region-specific documentation explicit
• Regulatory writing and interaction preparation for FDA- and/or EMA-oriented procedures
• Device and software readiness notes that do not collapse EU and US into one checklist
• Study and statistics packages that stay interpretable across regional reviewers

How we work across regions

1. Make differences explicit — what must stay separate vs what can be shared
2. Align workstreams — methodology, software and documentation with regional owners
3. Prepare packages — writing and readiness support for the applicable regional procedures
4. Route contact correctly — Canada & US vs Europe site versions

Method overview: How we work.

Site region

Choose Canada & US or Europe in the header for legal and contact routing. Deep links: /?region=ca · /?region=eu.

Accountability

We map which regional frameworks apply and prepare the work against them. Filings and manufacturer-of-record roles stay with the client. Role boundaries: Trust.

Related

Regulatory support · Device readiness · MedTech · Imprint